AMERICAN BIOMED, Minimally Invasive Technology (ABMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr David Summers who wrote (1066)	6/2/1998 7:28:00 PM
From: Jeffrey L. Henken	Read Replies (1) of 2887

Dr Ahn is much more than just a great surgeon. He is American BioMed's Chief Clinical Advisor. As such he was responsible for the development of the Ahn Thrombectomy Catheter which was approved for use by the FDA in January: americanbiomed.com I found when I originally talked to Dr Ahn in March that he was a very down to earth and honest man. He told me that the thrombectomy catheter that he had developed would be entering a limited market of around $25 to $30 million per year. American BioMed is gearing up to begin sales this quarter. Will this catheter take some significant market share? It just might do quite well. Why is that you and other readers of this thread might ask? Well it was completely designed by Dr Ahn who we both agree is a great surgeon. Dr Ahn has also helped to redesign American BioMed's catheter line as well and four more versions of the bilumen catheter could be approved by the FDA any day. What other impact has he had on the company's products? Look no further than the redesigned protocols for the phase II trials of the OmniCath in both the US and Japan: biz.yahoo.com biz.yahoo.com As the company's Chief Clinical Advisor Dr Ahn is having a tremendous impact on this company. I would hope that the Ahn Thrombectomy Catheter and the other design help will truly push the company towards profitability. He is more than a great vascular surgeon. He is designing and redesigning both new and old technology for our company. Dr Summers can I ask you what kind of degree you have? Exactly where did you get your degree from and in what fashion? I think we as American BioMed shareholders can trust Dr Ahn to make further progress with those products in R&D and help them become more viable, marketable devices. Don't you think so? GO ABMI! Regards, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next